Multiparametrische MRT von Adnextumoren

Mit der MRT kann die Dignität sonografisch unklarer Ovarialläsionen zuverlässig beurteilt werden, was für die optimale Therapie dieser Läsionen unerlässlich ist. Das ACR-O-RADS-MRT-Lexikon, das von Expert*innen für die Bildgebung des weiblichen Beckens erarbeitet wurde, enthält standardisierte Deskriptoren, mit denen Ovarialläsionen charakterisiert und dadurch in O-RADS-MRT-Risikoklassen eingeordnet werden können.

Schlüsselwörter

O-RADS-MRT-Risiko-Score - Adnextumor

Keywords

O-RADS MRI Risk Stratification System - Adnexal lesion

• Literatur

• 1 Thomassin-Naggara I, Poncelet E, Jalaguier-Coudray A. et al. Ovarian-Adnexal Reporting Data System Magnetic Resonance Imaging (O-RADS MRI) Score for Risk Stratification of Sonographically Indeterminate Adnexal Masses. JAMA Netw Open 2020; 3: e1919896
• 2 Choi JI, Park SB, Han BH. et al. Imaging features of complex solid and multicystic ovarian lesions: proposed algorithm for differential diagnosis. Clin Imaging 2016; 40: 46-56
• 3 Forstner R, Thomassin-Naggara I, Cunha TM. et al. ESUR recommendations for MR imaging of the sonographically indeterminate adnexal mass: an update. Eur Radiol 2017; 27: 2248-2257
• 4 Sala E, Rockall AG, Freeman SJ. et al. The added role of MR imaging in treatment stratification of patients with gynecologic malignancies: what the radiologist needs to know. Radiology 2013; 266: 717-740
• 5 Spencer JA, Forstner R, Cunha TM. et al. ESUR guidelines for MR imaging of the sonographically indeterminate adnexal mass: an algorithmic approach. Eur Radiol 2010; 20: 25-35
• 6 Thomassin-Naggara I, Aubert E, Rockall A. et al. Adnexal masses: development and preliminary validation of an MR imaging scoring system. Radiology 2013; 267: 432-443
• 7 Sadowski EA, Thomassin-Naggara I, Rockall A. et al. O-RADS MRI Risk Stratification System: Guide for Assessing Adnexal Lesions from the ACR O-RADS Committee. Radiology 2022; 303: 35-47
• 8 Alt C, Brunesch L, Danza FM. et al. ESUR Quick Guide to Female Pelvis Imaging 1.0; 2019. Accessed April 08, 2024 at: https://www.esur.org/wp-content/uploads/2022/10/ESUR_2019_-_ESUR_Quick_Guide_to_Female_Pelvis_Imaging.pdf
• 9 American College of Radiology (ACR). Leitkonzepte für das O-RADS MRT Risiko Scoring. Revidiert: Mai 2023. Accessed April 08, 2024 at: https://www.acr.org/Clinical-Resources/Reporting-and-Data-Systems/Translations
• 10 Wengert GJ, Dabi Y, Kermarrec E. et al. O-RADS MRI Classification of Indeterminate Adnexal Lesions: Time-Intensity Curve Analysis Is Better Than Visual Assessment. Radiology 2022; 303: 566-575
• 11 Sadowski EA, Maturen KE, Rockall A. et al. Ovary: MRI characterisation and O-RADS MRI. Br J Radiol 2021; 94: 20210157
• 12 Reinhold C, Rockall A, Sadowski EA. et al. Ovarian-Adnexal Reporting Lexicon for MRI: A White Paper of the ACR Ovarian-Adnexal Reporting and Data Systems MRI Committee. J Am Coll Radiol 2021; 18: 713-729
• 13 Nougaret S, Lakhman Y, Bahadir S. et al. Ovarian-Adnexal Reporting and Data System for Magnetic Resonance Imaging (O-RADS MRI): Genesis and Future Directions. Can Assoc Radiol J 2023; 74: 370-381
• 14 Rizzo S, Cozzi A, Dolciami M. et al. O-RADS MRI: A Systematic Review and Meta-Analysis of Diagnostic Performance and Category-wise Malignancy Rates. Radiology 2023; 307: e220795
• 15 Reinhold C, Sadowski EA, Rockall A. et al. Authors’ Response. J Am Coll Radiol 2021; 18: 1594-1595
• 16 Thomassin-Naggara I, Belghitti M, Milon A. et al. O-RADS MRI score: analysis of misclassified cases in a prospective multicentric European cohort. Eur Radiol 2021; 31: 9588-9599
• 17 Sadowski E, Reinhold C, Maturen K. et al. Orads MRI Calculator. Accessed April 08, 2024 at: http://oradsmricalc.com
• 18 Hottat NA, Badr DA, Van Pachterbeke C. et al. Added Value of Quantitative Analysis of Diffusion-Weighted Imaging in Ovarian-Adnexal Reporting and Data System Magnetic Resonance Imaging. J Magn Reson Imaging 2022; 56: 158-170
• 19 Assouline V, Dabi Y, Jalaguier-Coudray A. et al. How to improve O-RADS MRI score for rating adnexal masses with cystic component?. Eur Radiol 2022; 32: 5943-5953